Campath-1H, a humanized mAb undergoing clinical trials for treatment of leukemia, transplantation and autoimmune diseases, produces substantial lymphocyte depletion in vivo. The antibody binds to CD52, a highly glycosylated molecule attached to the membrane by a glycosylphosphatidylinositol anchor. Cross-linked Campath-1H is known to activate T cells in vitro. We have investigated the molecular basis for these effects by comparing the protein tyrosine phosphorylation signals induced by Campath-1H and the CD3 mAb OKT3 in primary T cells, and in CD45 ⍣ TCR ⍣ , CD45 -TCR ⍣ and CD45 ⍣ TCR -Jurkat subclones transfected with CD52. Our results show that Campath-1H triggers similar tyrosine phosphorylation events as OKT3 in both primary T cells and in the CD45 ⍣ TCR ⍣ Jurkat sub-clone, albeit at quantitatively lower levels. However, no phospholipase Cγ1 activation nor calcium signals were detected in response to CD52 ligation. The CD52-mediated induction of protein tyrosine phosphorylation was absolutely dependent upon the expression of both the TCR and the CD45 phosphotyrosine phosphatase at the cell surface. Cross-linking of Campath-1H was essential for signal transduction in all cells investigated. Fluorescence resonance energy transfer was used to demonstrate CD52 homo-association at the cell surface in Jurkat T cells in a TCR-and CD45-independent manner, and CD52-TCR association in CD45 ⍣ TCR ⍣ cells. We propose a model to explain the activating effects of Campath-1H in which CD52 mAb cross-linking causes the trapping of TCR polypeptides within molecular complexes at the cell surface, thereby inducing signals via the TCR by a process which depends on the CD45-mediated regulation of the p56 lck and p59 fyn tyrosine kinases.
Introduction
T cell activation not only requires the engagement of the TCR, Campath-1H, a humanized antibody (8,9), is directed at CD52, a small heavily glycosylated protein expressed at but also the participation of additional co-stimulatory receptors to induce optimal T cell proliferation (1). Several lymphocyte high levels (5ϫ10 5 molecules/cell) on human lymphocytes and monocytes (10,11). CD52 is a very good target for antigens with a diverse range of extracellular domains, but attached to the membrane with a glycosylphosphatidylinositol complement-mediated lysis and antibody-dependent cellular cytotoxicity (12), and depletes T cells and B cells efficiently (GPI) anchor, have also been shown to transduce signals resulting in proliferation, IL-2 production and Ca 2ϩ mobilizain vivo. Campath-1H has been used in clinical trials, many still in progress, to treat T and B cell malignancies, renal tion. These proteins include Thy-1 (2), Qa-2 (3), Ly-6 (4), human decay-accelerating factor (CD55) (5), CD59 (6) and transplant rejection, rheumatoid arthritis, systemic vasculitis, and multiple sclerosis (13-17). CD73 (7). Antibodies to these molecules are mitogenic in vitro and may mimic the interaction of the natural ligand(s) in vivo.
The structure of CD52 has been extensively studied (18) (19) (20) .
Tone, University of Oxford, UK). Stable transfectants were -6)-carboxamido)-hexanoic acid succinimidyl ester (Molecular Probes, Eugene, OR) as described (30) . The use of a capital F isolated using 1 mg/ml G418 (Sigma). Clones appeared after 3 weeks and were selected according to their phenotype as or R in front of the name of an antibody or F(abЈ) fragment designates fluoresceinated and rhodaminated antibodies determined by FACS analysis.
respectively. The dye:protein ratios varied between 2 and 4, Cell activation and immunoblotting and were separately determined for each labeled aliquot by spectrophotometric measurements. The fluorescently tagged YTH 360.10.1 and Campath-1H were used to ligate CD52 at concentrations at 5-50 µg/ml with 2-10ϫ10 6 cells in 100 µl.
antibodies and F(abЈ) fragments retained their binding capacity according to competition assays with identical, but The best signal:noise ratio was obtained using 2ϫ10 6 cells per assay and 5 µg/ml Campath-1H or 10 µg/ml YTH 360.10.1.
unlabeled antibodies. For labeling of cell surface antigens, cells were washed The concentration of cross-linking antibody was kept constant at 100 µg/ml. Cells in 100 µl serum-free RPMI were twice and resuspended in PBS. About 10 6 cells in 50 µl of PBS were incubated with fluorescently tagged antibodies incubated with antibody for 1 min followed by addition of cross-linking antibody for 5 min (unless otherwise stated), or F(abЈ) fragments at saturating concentration for 30 min on ice in the dark. The applied antibody concentration (100-washed in medium and then lysed in lysis buffer (1% NP-40, 10 mM Tris, pH 7.5, 150 mM NaCl, 50 mM NaF, 20 mM 200 µg/ml) saturated all available binding sites and produced at least partly monomeric binding of the antibodies that Na 4 P 2 O 7 , 1 mM Na 3 VO 4 , 1 mM EGTA, 10 mM EDTA, 1 mM AEBSF, and 2 µg/ml each of aprotinin and leupeptin) for reduced the possibility of cross-linking. The excess mAb or F(abЈ) fragment was removed by washing the cells twice in 10 min on ice. Post-nuclear lysates were either used for solidphase immunoprecipitation or directly subjected to SDS-PBS. Cells were either used immediately for measurements or were fixed in 1% formaldehyde. Results obtained with live PAGE analysis. Lysates from 5ϫ10 7 and 10 8 Jurkat cells were used per assay for immunoprecipitating with Fb2 and PLCγ1 and fixed cells were similar. Antibodies were centrifuged at 100,000 g for 30 min before use to avoid possible aggregation. mAb respectively. Proteins were transferred to Immobilon-P, and probed with 4G10 and GAM-HRP. Bands were visualised Flow cytometric energy transfer measurements were carried out using a modified Becton Dickinson FACStar Plus using the ECL system (Amersham Pharmacia Biotech, Little Chalfont, UK) and autoradiography. flow cytometer to determine FRET efficiency between F-and R-conjugated mAb and F(abЈ) fragments on a cell-by-cell Calcium assay basis. A detailed description of the method has been given elsewhere (31, 32) . In brief, fluorescence was excited with the Calcium assays were carried out as previously described (28) . Briefly, 5ϫ10 6 cells/ml were loaded for 30 min at 37°C 488 and 514 nm lines of an argon ion laser, and fluorescence emission was detected at 540 Ϯ 20 and Ͼ580 nm for the with 3 µM Indo-1 (Molecular Probes) in RPMI/10 mM HEPES supplemented with 2% FCS and then washed 3 times in 488 nm excitation, and Ͼ580 nm for the 514 nm excitation. Correction factors for the spectral overlap between the fluor-HBSS plus 0.2% FCS. The cells (10 5 cells/ml) were prewarmed for 2 min at 3°C and then stimulated with first antibody escent dyes were obtained from data measured on singlelabeled cells. Forward angle light scattering (at 514 nm) was (either OKT3 or Campath-1H) for 1 min, followed by crosslinking antibody SAM or GAH Ig respectively. Increases in used to gate out debris. The calculated energy transfer efficiency (E) was expressed as the ratio of the number of intracellular Ca 2ϩ were measured by a FACStar Plus using CellQuest software (Becton Dickinson).
excited donor molecules tunnelling their excitation energy to the acceptor and the number of all excited molecules. Energy Inositol phosphate (InsP) assay transfer was calculated on a cell-by-cell basis on 10,000 cells using list mode data. The transfer efficiency is related to the InsP analysis was carried out according to the method of Berridge et al. (29) . Briefly, cells were labelled over inverse sixth power of the separation between the donor and the acceptor when the orientation factor of the donor's night with 1 µCi/ml myo-[ 3 H]Inositol (Amersham Pharmacia Biotech). Cells (2ϫ10 6 ) cells were incubated in a final volume excitation and the acceptor's emission dipoles can be considered as a statistical average of random orientations of 200 µl for 10 min with OKT3 (5 µg/ml), Campath-1H (20 µg/ml) and then GAH (100 µg/ml) or left untreated. (33) . The calculated energy transfer efficiency has an extremely high sensitivity to changes in distances within the Incubations were performed in triplicate. The reactions were terminated by addition of 750 µl chloroform: methanol and range 2-10 nm. Larger energy transfer efficiency may reflect closer physical association of the donor-and acceptor-labeled left on ice. Then 200 µl chloroform and water were added sequentially, mixed and spun for 1 min in a microfuge, and antibodies or a larger density of acceptor-labeled antibodies in the vicinity of donor-labeled antibodies. 800 µl of supernatant was removed and applied to a 750 µl Dowex column. After washing, total InsP was eluted with 3 ml of 0.1 M formic acid/1 M ammonium formate and subResults jected to liquid scintillation counting.
CD52-induced signal transduction in primary human T cells Fluorescence resonance energy transfer (FRET)
For labeling of antibodies and F(abЈ) fragments with fluorescent
In light of previous results implicating p56 lck and p59 fyn in the signals mediated by GPI-linked molecules, we expected that probes, purified aliquots of purified mAb and F(abЈ) fragments were conjugated with 6-(fluorescein-5-carboxamido)-hexanoic CD52 mAb also would induce increases in protein tyrosine phosphorylation in T cells. This was demonstrated by preparacid succinimidyl ester and 6-(tetramethylrhodamine-5-(and 90-120 kDa. Phosphorylation levels began to decline after 10 min of cross-linking. Similar results (data not shown) were obtained using the humanized Campath-1H mAb, showing that the humanization of the mAb had not caused any obvious T cell activation through GPI-linked molecules is thought to changes in its activating potential when compared with the be dependent on the expression of a functional TCR (23, 24) . rat mAb. For both the rat and humanized CD52 mAb, crossIn order to investigate whether CD52-mediated signalling is linking using secondary antibodies was found to be essential related to TCR-induced tyrosine phosphorylation events, we for the induction of detectable increases in tyrosine phosphocompared CD52-induced phosphorylation with that caused rylation (data not shown). Since some tyrosine phosphorylation by ligation of the TCR. Figure 2 (A) shows that cross-linked events may not be readily visible in whole cell lysates, we Campath-1H ( Fig. 2A , lane 2) and cross-linked CD3 mAb precipitated tyrosine phosphorylated proteins from CD52-OKT3 ( Fig. 2A , lane 3) induced increases in tyrosine phosactivated cells using the specific Fb2 mAb followed by phorylation in an apparently similar array of proteins. However, immunoblotting with a phosphotyrosine mAb. Figure 1 (B) in this as in other experiments, the phosphorylation signals shows that increases in tyrosine phosphorylation in additional induced by Campath-1H were significantly lower than those proteins of mol. wt 21 and 36 kDa could also be clearly triggered upon TCR ligation. detected using this approach, besides those noted in whole Many of the proteins which become tyrosine phosphorylated cell lysates (cf. Fig 1A) . A small degree of variation was noted upon TCR ligation have been previously identified, and include in the signals between T cell preparations from different blood the TCR ζ chain, the ZAP-70 tyrosine kinase, the protodonors, e.g. the proteins at~45 kDa in lane 2 or 140 kDa in oncogenes p95 vav and p120 cbl , and the adaptor proteins lane 3 of Fig. 1 (28, 36) , plays a key role in initiating a signalling cascade which couples the TCR to intracellular by CD52 mAb were lower than those triggered by OKT3. It should also be noted that Jurkat cells were stimulated with signals. Figure 2 (B, left panel) shows that both Campath-1H (Fig. 2B , lane 2) and OKT3 (Fig. 2B, lane 3) triggered OKT3 without further addition of a cross-linking reagent, whereas increases in tyrosine phosphorylation in response to increases in the p21 TCR ζ phosphoisomer, although the level of phosphorylation induced by Campath-1H was much CD52 stimulation were only observed following cross-linking of CD52 mAb (data not shown). Furthermore, the induction lower than that induced by OKT3, despite the presence of comparable amounts of the non-phosphorylated TCR ζ of TCR ζ chain phosphorylation was weak in Jurkat cells in response to OKT3 and was not detectable upon CD52 polypeptide in the immunoprecipitates (cf. Fig. 2B , right panel). Immunoblotting with a ζ chain-specific antibody also ligation. Interestingly, in the B8 and C2 sub-clones no Campath-1H-or OKT3-induced tyrosine phosphorylation revealed that the amount of ζ chain polypeptide phosphorylated by OKT3 was small in relation to the total TCR ζ was observed (Fig. 4A , lanes 5 and 6, and data not shown), showing that CD52 signal transduction is dependent precipitated (cf. the small zeta-p signal at 21 kDa with the major zeta-0 signal at 16 kDa) and in fact was non-detectable upon CD45 and TCR expression. In addition, CD45 -cells had less background protein phosphorylation than CD45 ϩ upon CD52 ligation. These results confirm that the 21 kDa tyrosine phosphorylated protein illustrated in Figs 1(B) and cells (Fig. 4A, cf. lanes 1 and 4) . CD52 signal transduction was further characterized in the 2(A) was TCR ζ.
The adaptor protein Grb-2 is known to bind to multimeric Jurkat sub-clones by precipitating tyrosine phosphorylated proteins using the Fb2 mAb and then identifying the molecular complexes in T cells containing proteins which become tyrosine phosphorylated upon TCR ligation. These proteins by immunoblotting. Figure 4 (B) shows that ligation of Campath-1H induced increased tyrosine phosphorylation include p120 cbl , p95 vav , SLP-76 and LAT (37, 38) . To investigate the tyrosine phosphorylation of these proteins in response to of ZAP-70, Vav and LAT. The induction of LAT phosphorylation was confirmed by precipitating LAT with the immobilized Campath-1H, immobilized Grb-2 fusion protein precipitates from activated cells were immunoblotted with phosphotyrosine Grb-2 fusion protein followed by immunoblotting with phosphotyrosine mAb (data not shown). In contrast, no mAb. Figure 2(C) shows that the profile of phosphorylated proteins appeared very similar irrespective of whether the increase in phosphorylation of PLCγ1 was detectable, although a clear PLCγ1 phosphorylation signal was observed cells were activated with Campath-1H (Fig. 2C, lane 2) or OKT3 (Fig. 2C, lane 3) . There was a marked increase in in response to OKT3. phosphorylation in both cases in the pp36 protein recently Campath-1H fails to trigger Ca 2ϩ or InsP in human T cells cloned and re-named LAT (37), as well as in proteins provisionally identified by their electrophoretic mobility as SLP-76, Mobilization of intracellular Ca 2ϩ is an important event preceding cell proliferation in response to TCR ligation. As p95 vav and p120 cbl . Taken together these results suggest that CD52 ligation induces increases in tyrosine phosphorylation cross-linked Campath-1H plus PMA induces proliferation of human T cells in vitro (21), we investigated Ca 2ϩ signalling in many or even all of the same proteins which become phosphorylated upon TCR stimulation, suggesting that CD52 in primary T cells and in the CD52-transfected Jurkat subclones. Whereas cross-linked OKT3 triggered a transient may utilize the molecular signalling machinery of the TCR to stimulate intracellular signalling pathways.
Ca 2ϩ signal in primary T cells, in which~50% of the cells responded, cross-linked Campath-1H failed to do so (Fig. 5) .
The role of CD45 and the TCR in CD52-mediated signalling
Similarly, in the CD45 ϩ TCR ϩ A12 Jurkat sub-clone, as also illustrated in Fig. 5 , no detectable calcium signal was induced To obtain a fuller understanding of the role of the TCR in CD52-mediated signal transduction and, in particular, to in response to the cross-linking of Campath-1H, although the OKT3-stimulated calcium signal was readily detectable. As elucidate the possible role of CD45 in this process, we used the Jurkat E6 (CD45 ϩ TCR ϩ , A12), J45.01 (CD45 -TCR ϩ , B8) expected, no OKT3 or Campath-1H stimulated calcium signals were detectable in the B8 or C2 sub-clones (data not shown). and 31-13 (CD45 ϩ TCR -, C2) sub-clones. Initial analysis revealed that CD52 expression on Jurkat cells was~10-fold
Cross-linked Campath-1H was tested at mAb concentrations in the range 1-100 µg/ml, but in no case was a calcium signal less than its expression on primary T cells (data not shown). Therefore we transfected each sub-clone with CD52 cDNA detected in either primary T cells or Jurkat cells (data not shown). Since the assays illustrated in figures were carried and selected stable transfectants expressing CD52 at levels comparable with those found in primary human T cells, as out over short periods of only 6 min, we considered that Campath-1H might be inducing a much slower and more illustrated in Fig. 3 . The low CD45 expression detected on the J45.01 sub-clone (B8) was similar to that earlier described gradual rise in intracellular Ca 2ϩ . However, monitoring of cells over a 30 min period following CD52 ligation did not lead to for these cells, a level insufficient to promote TCR-mediated signals (38). The expression of p56 lck and p59 fyn in the any detectable changes in calcium levels (data not shown).
We also considered that Campath-1H might be inducing a selected transfectants was similar, as established by immunoblotting, although the CD45 ϩ TCR -C2 sub-clone expressed negative signal which counteracted its possible ability to mobilise intracellular calcium. To test this hypothesis A12 approximately twice as much p59 fyn as the A12 and B8 subclones (data not shown).
cells were preincubated with cross-linked Campath-1H and then stimulated with OKT3 to determine whether the OKT3-In the A12 CD45 ϩ Jurkat sub-clone, both Campath-1H and OKT3 (Fig. 4A, lanes 2 and 3) induced a similar profile of triggered Ca 2ϩ signal would be reduced. However, no inhibi- tion of the CD3-stimulated calcium signal was observed (data
CD52-TCR and CD52-CD52 association at the T cell surface not shown).
To investigate further the possible relationship between CD52 The failure of Campath-1H to induce a calcium signal is and the TCR at the T cell surface, we employed the FRET consistent with the lack of inducible PLCγ1 tyrosine phostechnique to measure possible associations of CD52 with the phorylation following CD52 cross-linking (Fig. 4B) . To assess TCR and other cell surface receptors. FRET analysis has the whether Campath-1H could stimulate activation of PLCγ1, we advantage that it avoids the use of detergent and enables measured InsP production in the A12 CD45 ϩ Jurkat subinteractions to be detected on intact cells when molecules clone in response to either TCR or CD52 ligation. As Table 1 are juxtaposed within distances of 10 nm or less. In the illustrates, a 2-to 3-fold increase in InsP was generated in present work fluorescein (F) and rhodamine (R) were used response to CD3 ligation, as expected, but no detectable as the fluorescent probes, and the relevant mAb were InsP production was observed in response to cross-linked directly conjugated to one or other of the probes. R-CD52 Campath-1H.
and F-CD52 were used to study CD52 homo-association. In summary, therefore, CD52 ligation induces a profile of Previous experience using this technique suggests that tyrosine phosphorylated proteins which appears qualitatively energy transfer values of Ͼ10% indicate that a significant similar but quantitatively lower to that induced upon TCR degree of association is taking place (27, 30) . Figure 6 (A) ligation in both primary and Jurkat T cells, and these signalling shows that substantial energy transfer occurred between events are dependent upon both CD45 and TCR expression.
CD52 molecules on the surface of the CD52 hi -transfected However, CD52 signal transduction is not identical to the Jurkat T cells, demonstrating homo-association of CD52. This signals triggered by a CD3 mAb because neither PLCγ1 homo-association was independent of the expression of CD45 activation nor calcium signals were detected in response to or the TCR, because similar levels of energy transfer between CD52 ligation in contrast to the large PLCγ1 activation and R-CD52 and F-CD52 were found on all three Jurkat subclones (Table 2 ). The homo-association was not the result of calcium signals measured in response to TCR ligation. association were observed in the three Jurkat sub-clones investigated (Table 2) , so confirming the selectivity of the CD3-CD52 and CD52-CD52 associations. A low degree of association was, however, detected between the TCR and CD45.
We considered that if significant CD3-CD52 association was occurring on the surface of TCR ϩ CD45 ϩ cells, then unlabeled Campath-1H might perturb the binding of F-CD3 mAb to the TCR. Figure 6 (B) shows that this in fact occurred and in the presence of the CD52 mAb the binding of F-CD3 to the TCR was substantially reduced (overall by 37%) on the A12 TCR ϩ CD45 ϩ sub-clone. Two distinct populations of cells differing in their ability to bind CD3 mAb were observed when Campath-1H was present, presumably reflecting differences in the degree of interaction between CD52 and the TCR on different cells. For example, some cells might contain a higher level of large CD3-CD52 complexes in which Campath-1H would only mask the binding of F-CD3 to those TCR closest to CD52, whereas masking by Campath-1H would be expected to be more effective for smaller CD3-CD52 aggregates. When we repeated the experiment illustrated in Fig. 6(B) , only now using the B8 TCR ϩ CD45 -sub-clone, Campath-1H binding reduced F-CD3 binding overall by only 22%, consistent with the lower CD3-CD52 association detected on this sub-clone by FRET analysis (cf. Table 2 ). Why CD3-CD52 association is lower on cells lacking CD45 expression is currently unknown. No competitive effects were noted between other mAb pairs tested, including CD52 and CD4, and CD52 and CD45, on either A12 or B8 sub-clones (data not shown), consistent with the apparent lack of association between these antigens as revealed by FRET energy transfer values (Table 2) .
Discussion
The findings in this paper represent the first molecular analysis of the signalling functions of the CD52 antigen. Ligation of CD52 in either primary T cells or in CD52-transfected Jurkat T cells results in the induction of a panoply of tyrosine TCR and CD45 at the cell surface (Fig. 4) , where CD52 or samples of whole cell lysates used for immunoprecipitations (right molecules are found in homo-associated clusters as well as panels) from A12 cells stimulated with GAH alone (lane 1), Campathin interaction with the TCR (Fig. 6 ). 39), Ly-6A/E (24, 40), CD55 (41) and CD59 (42) are dependent on TCR expression at the cell surface, and in particular on the transducing actions of the TCR ζ chain (39, 40) . It is well established that TCR-mediated signalling events are aggregation caused by Campath-1H IgG itself since R-F(abЈ) and F-F(abЈ) fragments derived from Campath-1H also dependent on the expression of the CD45 transmembrane phosphotyrosine phosphatase, as demonstrated by the showed similar energy transfer values (Table 2) . Interestingly, a significant association of CD52 with the TCR also occurred uncoupling of the TCR from intracellular signals in mutant cells lacking CD45 expression (43-45), as well as the defects on the TCR ϩ CD45 ϩ sub-clone (Fig. 6A) , but the energy transfer efficiency significantly decreased from 25 Ϯ 8% to 7 in thymic development and signalling which occur in CD45 -/-mice (28, 46) . Lack of CD45 expression correlates with hyper-Ϯ 3% in the cells lacking CD45 expression (Table 2) . No significant levels of CD4-CD52, CD4-CD45 or CD52-CD45 phosphorylation and dysfunction of its p56 lck and p59 fyn Fig. 5 . Campath-1H fails to trigger calcium signals in primary T cells and Jurkat A12 sub-clone. Calcium assays were carried out in Indo-1-loaded cells. Cells were stimulated with 5 µg/ml OKT3 for 1 min followed by 50 µg/ml SAM (primary T cells), or with 20 µg/ml Campath-1H for 1 min followed by 100 µg/ml GAH, or with 5 µg/ml OKT3 alone (Jurkat A12 cells). Control experiments were performed with cross-linkers only (SAM or GAH as appropriate, labelled XL). to be generally the case that GPI-linked molecule signal transduction depends on the TCR and its CD45-regulated tyrosine kinases. A surprising exception to the generalization that CD52 and tyrosine kinase substrates which are involved in the CD3 mAb appear to trigger similar signals was the finding initiating events of TCR coupling to intracellular signalling that the CD52 mAb failed to phosphorylate or activate PLCγ1 pathways (28, (47) (48) (49) , and evidence that p56 lck is in its hyperin Jurkat cells (Table 1) nor induce detectable calcium signals phosphorylated dysfunctional conformation has previously in either primary T cells or in Jurkat cells (Fig. 5) . Since been reported for the CD45 -J45.01 Jurkat sub-clone used calcium assays were carried out by FACS analysis, it is in the present work (50) . Our finding that CD52-induced unlikely that there was a small population of CD52-signalling is dependent on the expression of CD45 is therefore responsive cells present, since these should have been consistent with a model in which CD52 transduces signals to detected using this technique. However, we cannot exclude the cell interior by utilizing the signalling functions of the TCR the possibility that calcium transients were induced in single polypeptides in conjunction with the actions of CD45-activated cells, possibly over a range of times longer than the 30 min p56 lck and p59 fyn . Such a model is supported by the similar profile of tyrosine phosphorylated substrates induced upon employed in the present work. The finding that the mitogenic effects of cross-linked Campath-1H are inhibited by cyclosporin A (21) certainly points to a role for Ca 2ϩ -activated calcineurin in the proliferative signalling cascade triggered by CD52 ligation. Our results contrast with those reported for CD59 mAb which induce calcium transients in U937 cells (6), human neutrophils (51) and in Jurkat T cells (42), and with Thy-1 mAb which also trigger calcium signals (23) . On the other hand, a CD55 mAb did not induce calcium signals in Jurkat T cells (41). The failure of CD52 mAb in the present work to trigger a significant mobilization of intracellular Ca 2ϩ may reflect the quantitatively lower levels of protein tyrosine phosphorylation, particularly LAT phosphorylation ( Fig. 4A and B) induced by CD52 mAb in contrast to OKT3. It is thought that the release of intracellular Ca 2ϩ in T cells depends on a complex series of tightly coordinated TCR-induced molecular events, including PLCγ1 phosphorylation and recruitment to the plasma membrane, subsequent PLCγ1 activation with the consequent production of inositol trisphosphate, the generation of sufficient phosphatidylinositol bisphosphate substrate, and the regulation of ion channels (52) , as well as the regulation of these events by LAT phosphorylation (53) . Further work will be necessary to determine why Campath-1H does not induce PLCγ1 phosphorylation, InsP production and a consequent calcium signal. The most likely explanation is that the stimulation of LAT phosphorylation is too low to allow efficient recruitment of PLCγ1 to the plasma membrane, thereby preventing its effective phosphorylation and activation. Our finding that CD52 homo-associates, and at the same time associates with the TCR (Fig. 6A and B, Table 2 ), suggests a model of CD52 signal transduction which may that the polypeptides of the TCR fulfil this role. Current evidence suggests that GPI-linked molecules are preferentially localized with glycosphingolipids in distinct microdomains in the cell membrane (53, 54) and that membrane compartmentation is required for efficient T cell activation (54) . GPI-linked molecules are not exclusively localized in lines did contain significant levels of CD45 in one study (57) , but not in another study (58) .
Investigations of intact cells in
Mean values of energy transfer histograms containing data derived from 10,000 cells are presented. SD values were calculated from the absence of detergent will be required to resolve this issue four independent measurements. Antibodies used were IgG except (55) . Our own finding that CD52 associates with the TCR for CD52 Campath-1H F(abЈ) fragments used as indicated. Antibodies ( Fig. 6A and B, Table 2 ) is consistent with the presence of written first were fluorescein labeled and were used as energy transfer the TCR within GPI-rich lipid microdomains.
donors for rhodaminated antibodies written second.
ND, not determined.
Irrespective of the precise location of the TCR and CD45 unique way in which GPI-linked molecules are anchored to the outer leaflet of the plasma membrane may result in References their effectiveness in trapping other cell-surface glycoproteins upon extensive cross-linking. In fact, it has been shown that
